Mutation is the raw material of evolution and a necessary precondition for adaptation to a hostile environment. On the other hand, mutation changes what works, and rarely for the better, a truth equally relevant for a virus as for a human. In a new study in PLOS Biology, José Cuevas, Ron Geller, Rafael Sanjuán, and colleagues measured the mutation rate of HIV-1, the virus that causes AIDS, in patient´s cells (Fig 1) . They show that the HIV-1 mutation rate is far higher than previously thought, due mainly to the efforts of a cellular enzyme. The high rate of mutation caused by the enzyme may protect the host from virulence but may also promote evolution of HIV to escape that protection.
overall mutation rate in this patient was four times that of the average of the other patients, suggesting that the virus' inability to disable A3 led to the increase in the mutation rate.
Yet while a high mutation rate seems to be helpful in defending against infection, the authors found some evidence that a low mutation rate may not be better than none at all. Rapid progressors in this study had higher rates of low-level A3 editing (i.e., editing that introduced few mutations per genome) than normal progressors, and the rate of low-level editing (which was nonetheless higher than reverse transcriptase alone) correlated with a higher viral load. Together, these results suggest that the increase in genetic diversity from a small number of mutations may promote adaptation rather than fight infection.
More work in larger numbers of patients will be needed to confirm these results, but the implications are important for understanding, and treating, HIV infection. Mutation may be lethal, but it also leads to development of drug resistance and thwarts attempts at vaccination. Understanding how mutation is governed in HIV may lead to better strategies for promoting its antiviral benefits and preventing its liabilities. 
